Italia markets closed

BMY Sep 2024 40.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,8200-0,0600 (-6,82%)
Alla chiusura: 10:42AM EDT
Schermo intero
Chiusura precedente0,8800
Aperto0,8200
Denaro0,7700
Lettera0,8100
Prezzo d'esercizio40,00
Scadenza2024-09-20
Min-Max giorno0,8200 - 0,8200
Contratto - Min-MaxN/D
Volume5
Open Interest2,67k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri